Albert David Faces Evaluation Adjustment Amid Declining Performance and Mixed Market Signals

May 15 2025 08:14 AM IST
share
Share Via
Albert David, a microcap in the Pharmaceuticals & Drugs sector, has experienced a recent evaluation adjustment reflecting changes in its financial standing. This shift highlights trends in performance metrics and market position, amid challenges such as declining operating profits and mixed technical indicators, suggesting a complex market narrative.
Albert David, a microcap player in the Pharmaceuticals & Drugs industry, has recently undergone an evaluation adjustment that reflects a shift in its financial standing. This revision in its score highlights underlying trends that have emerged from the company's performance metrics and market position.

The stock has been characterized by a technical trend that is currently classified as mildly bearish, with various indicators such as MACD and Bollinger Bands showing mixed signals. The company's valuation metrics have also prompted a change, with key ratios indicating a shift from a more favorable assessment to a riskier outlook. Notably, the price-to-earnings ratio stands at 27.47, while the EV to EBITDA ratio is significantly high at 62.53, suggesting concerns regarding profitability and valuation.

In terms of performance, Albert David has faced challenges, with a notable decline in operating profits over the past five years. The latest quarterly results reveal a drop in net sales and a negative operating profit margin, further emphasizing the difficulties the company is encountering.

Overall, the evaluation adjustment for Albert David reflects a complex interplay of technical and valuation factors that are shaping its current market narrative.

Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News